Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres

FRANSEN, J.; POPA-DIACONU, D.; Hesselstrand, R.; CARREIRA, P.; VALENTINI, G.; BERETTA, L.; AIRO, P.; Inanc, MURAT; Ullman, S.; BALBIR-GURMAN, A.; SIERAKOWSKI, S.; ALLANORE, Y.; CZIRJAK, L.; RICCIERI, V.; GIACOMELLI, R.; GABRIELLI, A.; RIEMEKASTEN, G.; MATUCCI-CERINIC, M.; FARGE, D.; HUNZELMANN, N.; VAN DEN HOOGEN, F.; VONK, M.

doi:10.1136/ard.2010.144360

Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres

FRANSEN J., POPA-DIACONU D., Hesselstrand R., CARREIRA P., VALENTINI G., BERETTA L., ...Daha Fazla

ANNALS OF THE RHEUMATIC DISEASES, cilt.70, sa.10, ss.1788-1792, 2011 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 70 Sayı: 10
Basım Tarihi: 2011
Doi Numarası: 10.1136/ard.2010.144360
Dergi Adı: ANNALS OF THE RHEUMATIC DISEASES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1788-1792
İstanbul Üniversitesi Adresli: Evet

Özet

Objective Systemic sclerosis (SSc) is associated with a significant reduction in life expectancy. A simple prognostic model to predict 5-year survival in SSc was developed in 1999 in 280 patients, but it has not been validated in other patients. The predictions of a prognostic model are usually less accurate in other patients, especially from other centres or countries. A study was undertaken to validate the prognostic model to predict 5-year survival in SSc in other centres throughout Europe.